X4 Pharmaceuticals (XFOR) Depreciation and Depletion (2023 - 2025)
X4 Pharmaceuticals posted quarterly Depreciation and Depletion of $168000.0 for Q2 2025, up 143.48% year-on-year from $69000.0 in Q2 2024, and down 41.87% on a QoQ basis from $289000.0 in Q1 2025.
X4 Pharmaceuticals (XFOR) has 3 years of Depreciation and Depletion data on file, last reported at $168000.0 in Q2 2025.
- For the quarter ending Q2 2025, Depreciation and Depletion rose 143.48% year-over-year to $168000.0; the trailing twelve-month figure through Jun 2025 stood at $626000.0 (up 125.18% YoY), and the FY2025 full-year result was $500000.0, up 66.67% from the prior year.
- Depreciation and Depletion for Q2 2025 stood at $168000.0, down from $289000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $289000.0 in Q1 2025 and bottomed at $43000.0 in Q4 2023.
- The 3-year median for Depreciation and Depletion is $84500.0 (2024), against an average of $113000.0.
- The widest annual swing landed in 2024, when Depreciation and Depletion slipped 23.08%; it then jumped 366.13% in 2025.
- A 3-year view of Depreciation and Depletion shows it stood at $43000.0 in 2023, then jumped by 106.98% to $89000.0 in 2024, then jumped by 88.76% to $168000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $168000.0 (Q2 2025), $289000.0 (Q1 2025), and $89000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 104,000.00 |
| Sep 30, 2023 | 104,000.00 |